Latest Updates

October 2014

Treatment with testosterone improves cardiovascular risk factors in obese hypogonadal men, with or without type 2 diabetes mellitus

Key Points


Efficacy and safety of injectable TU for the treatment of hypogonadism


September 2014

Long-term testosterone therapy is associated with a reduction in obesity parameters, improved metabolic syndrome and health-related quality of life in men with hypogonadism

Key Points


Effects of testosterone replacement therapy in men with hypogonadism

Key Points:


August 2014

Testosterone Treatment and Heart Attack Risk
- New study shows testosterone treatment can even be beneficial

Key Points


Adverse health effects of testosterone deficiency in men

Hypogonadism, if left untreated, negatively impacts multiple health parameters:


July 2014

Effects of testosterone deficiency on body composition, strength and sexual function in men, and the tolerability of long-acting testosterone undecanoate in daily clinical practice

Key Points


Testosterone treatment in men with osteoporosis and subnormal serum testosterone levels

Key Points


June 2014

Testosterone and Prostate Cancer - a paradigm shift
"Bye-bye Androgen Hypothesis, Welcome Saturation Model"

Key Points


April 2014

Testosterone replacement therapy and its withdrawal in hypogonadal men with severe obesity

Key Points


March 2014

The role of testosterone in cardiovascular health

Key Points


February 2014

Testosterone treatment in obese hypogonadal men with type 2 diabetes

Key Points


January 2014

Testosterone replacement therapy can improve metabolic and sexual parameters in men with type 2 diabetes

Key Points


December 2013

Testosterone replacement therapy can improve components of metabolic syndrome

Key Points


November 2013

Testosterone replacement therapy can improve cardiovascular disease risk factors in patients with testosterone deficiency

Key Points


October 2013

Testosterone undecanoate can improve sexual function and quality of life in males with type 2 diabetes

Key Points


September 2013

Updated guidance on the diagnosis and treatment of hypogonadism: Focus on the European Association of Urology (EAU) Guidelines 2012

Key Points


August 2013

Obesity is strongly linked to hypogonadism in males regardless of age

Key Points


July 2013

Weight loss following testosterone treatment in hypogonadal men

Key Points


June 2013

Testosterone treatment and cardiometabolic health

Key Points


May 2013

Testosterone treatment and sleep disorders

Key Points


April 2013

Testosterone may be beneficial for metabolic syndrome-associated prostate inflammation

Key Points


March 2013

Testosterone for the treatment of obesity in hypogonadal men

Key Points


February 2013

Long-acting testosterone undecanoate is well tolerated in men with hypogonadism in daily clinical practice

Key Points

Access the Men's Health Knowledge Centre
Men's Health Knowledge Centre

View etiology, diagnosis and treatment options for hypogonadism and erectile dysfunction as well as a bimonthly updates section.

This information is intended for healthcare professionals only.If you are not a healthcare professional please visit our patient website